The Surveillance Error Grid
Klonoff, David C., Lias, Courtney, Vigersky, Robert, Clarke, William, Parkes, Joan Lee, Sacks, David B., Kirkman, M. Sue, Kovatchev, Boris, Aurand, Lisa, Benson, Carol, Bernhardt, Patricia, Blonde, Lawrence, Breton, Mark, Buckingham, Bruce, Cariski, Alan, Colburn, Scott, Flacke, Frank, Harrison, Bern, Herman, Carol, Hinzmann, Rolf, Johnson-Lyles, Denise, Karinka, Shridhara Alva, Landree, Leslie, Lebinger, Tessa, Lee, Scott, Mastrototaro, John, Peyser, Tom, Phillips, Stephen, Pinkos, Arleen, Price, David, Scott, Steve, Serrano, Katherine, Simmons, David
Published in Journal of diabetes science and technology (01.07.2014)
Published in Journal of diabetes science and technology (01.07.2014)
Get full text
Journal Article
PB2044: FINAL PATIENT‐REPORTED OUTCOMES FROM A PHASE 2, RANDOMISED TRIAL EVALUATING THE SAFETY AND EFFICACY OF POZELIMAB AND CEMDISIRAN IN PATIENTS WITH PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA
Hartford, Christopher, Nguyen, Quang P., Sherman, Steven, Pavani, Rodrigo, Aurand, Lisa, Rofail, Diana, Kelly, Richard
Published in HemaSphere (08.08.2023)
Published in HemaSphere (08.08.2023)
Get full text
Journal Article
P782: A PHASE 2, RANDOMIZED TRIAL EVALUATING THE SAFETY AND EFFICACY OF POZELIMAB AND CEMDISIRAN IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA
Jang, Jun‐Ho, Wong, Raymond, Pavani, Rodrigo, Aurand, Lisa, Nguyen, Quang P., Perlee, Lorah, Souttou, Amal, Weyne, Jonathan, Kelly, Richard
Published in HemaSphere (08.08.2023)
Published in HemaSphere (08.08.2023)
Get full text
Journal Article
P797: A PHASE 2, OPEN‐LABEL STUDY EVALUATING THE SAFETY AND EFFICACY OF COMBINATION POZELIMAB AND CEMDISIRAN THERAPY IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA WHO SWITCH FROM ECULIZUMAB
Kelly, Richard, Houghton, Nicola, Munir, Talha, Muus, Petra, Youngs, Nora, Aurand, Lisa, Senk, Brian, Pavani, Rodrigo, Perlee, Lorah, Souttou, Amal, Griffin, Morag
Published in HemaSphere (08.08.2023)
Published in HemaSphere (08.08.2023)
Get full text
Journal Article
Design and rationale of the ODYSSEY DM-DYSLIPIDEMIA trial: lipid-lowering efficacy and safety of alirocumab in individuals with type 2 diabetes and mixed dyslipidaemia at high cardiovascular risk
Müller-Wieland, Dirk, Leiter, Lawrence A, Cariou, Bertrand, Letierce, Alexia, Colhoun, Helen M, Del Prato, Stefano, Henry, Robert R, Tinahones, Francisco J, Aurand, Lisa, Maroni, Jaman, Ray, Kausik K, Bujas-Bobanovic, Maja
Published in Cardiovascular diabetology (25.05.2017)
Published in Cardiovascular diabetology (25.05.2017)
Get full text
Journal Article
Patient-Reported Outcomes from a Phase 2, Randomized Trial Evaluating the Safety and Efficacy of Pozelimab and Cemdisiran in Patients with Paroxysmal Nocturnal Hemoglobinuria
Hartford, Chris, Dain, Bradley, Sherman, Steven, Zhang, Yi, Pavani, Rodrigo, Aurand, Lisa, Rofail, Diana, Kelly, Richard
Published in Blood (15.11.2022)
Published in Blood (15.11.2022)
Get full text
Journal Article
A novel approach to preventing diabetic ketoacidosis in a patient treated with an insulin pump
Phillips, Ben D, Aurand, Lisa A, Bedwell, Michele M, Levy, James R
Published in Diabetes care (01.10.2003)
Published in Diabetes care (01.10.2003)
Get full text
Journal Article
19 Patient-reported outcomes from a phase 2, randomised trial evaluating the safety and efficacy of pozelimab and cemdisiran in patients with paroxysmal nocturnal haemoglobinuria
Hartford, Christopher, Nguyen, Quang P., Sherman, Steven, Pavani, Rodrigo, Aurand, Lisa, Rofail, Diana, Kelly, Richard J.
Published in Immunobiology (1979) (01.09.2023)
Published in Immunobiology (1979) (01.09.2023)
Get full text
Journal Article
A Phase 2, Randomized Trial Evaluating the Safety and Efficacy of Pozelimab and Cemdisiran in Patients with Paroxysmal Nocturnal Hemoglobinuria
Jang, Jun Ho, Wong, Raymond, Pavani, Rodrigo, Aurand, Lisa, Dain, Bradley, Perlee, Lorah, Souttou, Amal, Weyne, Jonathan, Kelly, Richard
Published in Blood (15.11.2022)
Published in Blood (15.11.2022)
Get full text
Journal Article
52-Week Open-Label Extension Data from a Phase 2 Study Evaluating the Safety and Efficacy of Pozelimab and Cemdisiran Combination Therapy in Patients with Paroxysmal Nocturnal Hemoglobinuria Who Switched from Eculizumab
Kelly, Richard J., Houghton, Nicola, Munir, Talha, Muus, Petra, Youngs, Nora, Aurand, Lisa, Mohan, Kosalai, Senk, Brian, Pavani, Rodrigo, Perlee, Lorah, Souttou, Amal, Griffin, Morag
Published in Blood (02.11.2023)
Published in Blood (02.11.2023)
Get full text
Journal Article
A Phase 2, Open-Label Study Evaluating the Safety and Efficacy of Combination Pozelimab and Cemdisiran Therapy in Patients with Paroxysmal Nocturnal Hemoglobinuria Who Switch from Eculizumab
Kelly, Richard, Houghton, Nicola, Munir, Talha, Muus, Petra, Youngs, Nora, Aurand, Lisa, Dain, Bradley, Pavani, Rodrigo, Perlee, Lorah, Souttou, Amal, Griffin, Morag
Published in Blood (15.11.2022)
Published in Blood (15.11.2022)
Get full text
Journal Article
17 A phase 2, randomized trial evaluating the safety and efficacy of Pozelimab and Cemdisiran in patients with paroxysmal nocturnal hemoglobinuria
Jang, Jun-Ho, Wong, Raymond, Pavani, Rodrigo, Aurand, Lisa, Nguyen, Quang P., Perlee, Lorah, Souttou, Amal, Weyne, Jonathan, Kelly, Richard J.
Published in Immunobiology (1979) (01.09.2023)
Published in Immunobiology (1979) (01.09.2023)
Get full text
Journal Article
18 A phase 2, open-label study evaluating the safety and efficacy of combination pozelimab and cemdisiran therapy in patients with paroxysmal nocturnal hemoglobinuria who switch from eculizumab
Kelly, Richard J., Houghton, Nicola, Munir, Talha, Muus, Petra, Youngs, Nora, Aurand, Lisa, Senk, Brian, Pavani, Rodrigo, Perlee, Lorah, Souttou, Amal, Griffin, Morag
Published in Immunobiology (1979) (01.09.2023)
Published in Immunobiology (1979) (01.09.2023)
Get full text
Journal Article
Comparison of three algorithms for initiation and titration of insulin glargine in insulin-naive patients with type 2 diabetes mellitus (既往从未使用过胰岛素的2型糖尿病患者使用三种不同的启用与滴定甘精胰岛素剂量方案的比较)
Dailey, George, Aurand, Lisa, Stewart, John, Ameer, Barbara, Zhou, Rong
Published in Journal of diabetes (01.03.2014)
Published in Journal of diabetes (01.03.2014)
Get full text
Journal Article